Edition:
United Kingdom

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

36.99USD
3:14pm GMT
Change (% chg)

$-1.24 (-3.24%)
Prev Close
$38.23
Open
$38.20
Day's High
$38.23
Day's Low
$36.71
Volume
91,628
Avg. Vol
794,900
52-wk High
$111.36
52-wk Low
$33.52

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.52 December 19 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 4 4 4 5
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.80 1.80 1.80 1.82

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 8 25.13 42.50 18.48 45.74
Quarter Ending Mar-19 6 53.41 148.00 20.55 49.02
Year Ending Dec-18 9 1,176.79 1,195.00 1,169.97 213.05
Year Ending Dec-19 9 261.23 605.00 82.30 236.98
Earnings (per share)
Quarter Ending Dec-18 9 -0.52 0.65 -0.80 -0.31
Quarter Ending Mar-19 6 -0.40 0.49 -0.70 --
Year Ending Dec-18 9 3.85 5.05 3.38 -0.97
Year Ending Dec-19 9 -1.79 1.21 -3.08 -0.90

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 26.08 27.76 1.68 6.44
Quarter Ending Jun-18 1,033.34 1,087.72 54.38 5.26
Quarter Ending Mar-18 35.62 38.02 2.40 6.75
Quarter Ending Dec-17 36.98 95.47 58.49 158.18
Quarter Ending Sep-17 117.32 152.93 35.61 30.35

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 25.13 25.13 30.30 30.30 45.74
Quarter Ending Mar-19 53.41 53.41 55.49 62.09 49.02
Year Ending Dec-18 1,176.79 1,176.79 1,181.56 1,181.49 213.05
Year Ending Dec-19 261.23 261.23 296.01 295.83 236.98

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 1 2 4
Quarter Ending Mar-19 0 0 0 1
Year Ending Dec-18 0 0 4 3
Year Ending Dec-19 0 0 0 2
Earnings